Nuevos diagnósticos de diabetes mellitus tipo 1 en niños durante la pandemia COVID-19. Estudio multicéntrico regional en España

Herrero, María Hernández; Mercader, Pilar Terradas; Martinez, Ester Latorre; Rovira, Albert Feliu; Zaragoza, Neus Rodríguez; Parada, Esther

doi:10.1016/j.endinu.2021.12.003

Cited by 11 publications

(5 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 6 Finally, from a Spanish study, Rahmati 1 selected incidence rate data that did not refer to the total population but to a selective population with a Northwest African (Maghreb) immigrant background (Table 1 ). 4 When the corrected data for these studies are used in a random‐effects model, the incidence rate during the pandemic was 13.5% (3.7%−24.3%) higher than that in the prepandemic period and not 63.7% (33.5%−100.8%) higher, as reported by Rahmati 1 (Table 1 ).…”

Section: Tablementioning

confidence: 72%

“… h Study of Lee 2022 3 excluded. i Data corrections for the studies Hernandez Herrero 2021, 4 Salmi 2022, 5 and Dilek 2021. 6 j Study of Bogale 2021 7 additionally included (not considered in Rahmati 2022 1 due to a putative missing value).…”

Section: Tablementioning

confidence: 99%

“…Moreover, Rahmati 1 used questionable effect sizes regarding the T1D incidence rate for three studies. 4 , 5 , 6 The effect size used for a Finnish study relates to the incidence rate of pediatric intensive care unit admission and not to the T1D incidence rate (Table 1 ). 5 Again, the effect size used for a Turkish study is not consistent with the original incidence rate data.…”

Section: Tablementioning

confidence: 99%

“…3A of Rahmati 2022. 1 Some numbers of (s)DKA/T1D cases used in Rahmati 2022 1 were revised to resemble the data given in the following original publications: Boboc 2021, 8 Goldman 2022, 9 Gottesmann 2022, 10 Hawkes 2021, 11 Hernandez Herrero 2021, 4 Ho 2021. 12 Supporting Information: Table S1 gives details of the data correction.…”

Section: (A)mentioning

confidence: 99%

See 3 more Smart Citations

Comments on Rahmati et al., The global impact of COVID‐19 pandemic on the incidence of pediatric new‐onset type 1 diabetes and ketoacidosis: A systematic review and meta‐analysis. J Med Virol. 2022; 1‐16 (doi: 10.1002/jmv.27996)

Rosenbauer

Stahl‐Pehe

Schlesinger

et al. 2022

Journal of Medical Virology

View full text Add to dashboard Cite

show abstract

Section: Tablementioning

confidence: 72%

Section: Tablementioning

confidence: 99%

Section: Tablementioning

confidence: 99%

Section: (A)mentioning

confidence: 99%

See 2 more Smart Citations

Comments on Rahmati et al., The global impact of COVID‐19 pandemic on the incidence of pediatric new‐onset type 1 diabetes and ketoacidosis: A systematic review and meta‐analysis. J Med Virol. 2022; 1‐16 (doi: 10.1002/jmv.27996)

Rosenbauer

Stahl‐Pehe

Schlesinger

et al. 2022

Journal of Medical Virology

View full text Add to dashboard Cite

show abstract

“…However, we did not observe any significant difference between these two periods ( p = 0.090). Some studies have suggested an increase in incidence during the pandemic, such as in Germany, 23 Finland, 24 Italy, 25 and Spain, 57 while others found no significant change during the pandemic compared to the prepandemic period in Kuwait 26 and Spain 27 . A recent meta‐analysis assessed the impact of the first wave of the COVID‐19 pandemic on the incidence of new‐onset T1DM in pediatric patients, reporting an IR of 32.39 per 100,000 person‐years, 58 which is higher than our results.…”

Section: Discussionmentioning

confidence: 99%

Incidence of type 1 diabetes mellitus in children and adolescents under 20 years of age across 55 countries from 2000 to 2022: A systematic review with meta‐analysis

Hormazábal‐Aguayo,

Ezzatvar,

Huerta‐Uribe

et al. 2023

Diabetes Metabolism Res

View full text Add to dashboard Cite

AimsThe aim of this study was to determine the global incidence of type 1 diabetes mellitus (T1DM) in children and adolescents under 20 years of age from 2000 to 2022.Materials and MethodsTwo reviewers searched three electronic databases (PubMed, Web of Science, and CINAHL) for studies published between January 2000 and November 2022. Pooled estimates of T1DM incidence with a 95% confidence interval (CI) per 100,000 person‐years were calculated by country/region, sex, age, and COVID‐19 pandemic period (pre‐COVID‐19 and pandemic).ResultsThe study included 126 studies from 55 countries and 18 regions. The incidence rate (IR) of T1DM from 2000 to 2022 was 14.07 (95%CI, 12.15–16.29) per 100,000 person‐years. Finland and high‐income North America had the highest IR, with 56.81 (95%CI, 55.91–57.73) and 28.77 (95%CI, 26.59–31.13) per 100,000 person‐years, respectively. The IR was 13.37 (95%CI, 10.60–16.88) per 100,000 person‐years in boys and 13.87 (95%CI, 11.51–16.70) per 100,000 person‐years in girls. There were statistically significant differences among different age ranges: 0–4 versus 5–9 and 10–14 years old (p < 0.001); 5–9 versus 15–19 (p < 0.001) and 10–14 versus 15–19 years old (p = 0.003). Finally, during the pandemic period (2020–2022), the IR was 24.84 (95%CI, 17.16–35.96) per 100,000 person‐years, which was higher but not significant compared with the prepandemic period (2017–2019) of 13.56 (95%CI, 7.49–24.56) per 100,000 person‐years (p = 0.090).ConclusionsThe IR of T1DM in children and adolescents under 20 years of age is substantial, especially during the pandemic period, although it varies across regions. More reliable data from additional countries are needed to determine the worldwide incidence of T1DM.

show abstract

The global impact of COVID‐19 pandemic on the incidence of pediatric new‐onset type 1 diabetes and ketoacidosis: A systematic review and meta‐analysis

Rahmati

Keshvari

Mirnasuri³

et al. 2022

Journal of Medical Virology

View full text Add to dashboard Cite

Viral infections may increase the risk of developing type 1 diabetes (T1D), and recent reports suggest that Coronavirus Disease 2019 (COVID‐19) might have increased the incidence of pediatric T1D and/or diabetic ketoacidosis (DKA). Therefore, this meta‐analysis aims to estimate the risk of global pediatric new‐onset T1D, DKA, and severe DKA before and after the COVID‐19 pandemic. A systematic search of MEDLINE/PubMed, CINAHL, Scopus, and EMBASE was conducted for articles published up to March 2022. A random‐effects meta‐analysis was performed to compare the relative risk of T1D and DKA among pediatric patients with T1D between the COVID‐19 pre‐pandemic and pandemic periods. We also compared glucose and HbA1c values in children who were newly diagnosed with T1D before and after the COVID‐19 pandemic. The global incidence rate of T1D in the 2019 period was 19.73 per 100 000 children and 32.39 per 100 000 in the 2020 period. Compared with pre‐COVID‐19 pandemic, the number of worldwide pediatric new‐onset T1D, DKA, and severe DKA during the first year of the COVID‐19 pandemic increased by 9.5%, 25%, and 19.5%, respectively. Compared with pre‐COVID‐19 pandemic levels, the median glucose, and HbA1c values in newly diagnosed T1D children after the COVID‐19 pandemic increased by 6.43% and 6.42%, respectively. The COVID‐19 pandemic has significantly increased the risk of global pediatric new‐onset T1D, DKA, and severe DKA. Moreover, higher glucose and HbA1c values in newly diagnosed T1D children after the COVID‐19 pandemic mandates targeted measures to raise public and physician awareness.

show abstract

Nuevos diagnósticos de diabetes mellitus tipo 1 en niños durante la pandemia COVID-19. Estudio multicéntrico regional en España

Cited by 11 publications

References 11 publications

Comments on Rahmati et al., The global impact of COVID‐19 pandemic on the incidence of pediatric new‐onset type 1 diabetes and ketoacidosis: A systematic review and meta‐analysis. J Med Virol. 2022; 1‐16 (doi: 10.1002/jmv.27996)

Comments on Rahmati et al., The global impact of COVID‐19 pandemic on the incidence of pediatric new‐onset type 1 diabetes and ketoacidosis: A systematic review and meta‐analysis. J Med Virol. 2022; 1‐16 (doi: 10.1002/jmv.27996)

Incidence of type 1 diabetes mellitus in children and adolescents under 20 years of age across 55 countries from 2000 to 2022: A systematic review with meta‐analysis

The global impact of COVID‐19 pandemic on the incidence of pediatric new‐onset type 1 diabetes and ketoacidosis: A systematic review and meta‐analysis

Contact Info

Product

Resources

About